There exists a paucity of structural innovation and limited molecular diversity associated with
molecular frameworks in drug discovery and biomolecular imaging/chemical probe design …

Simple Summary Many boron-containing compounds have been synthesized and proposed
as boron-delivery agents for boron neutron capture therapy for cancers, including brain …

Sufficient boron-10 isotope (10B) accumulation by tumor cells is one of the main
requirements for successful boron neutron capture therapy (BNCT). The inability of the …

The past decade has witnessed a rapid growth in scientific studies on zero-dimensional (0D)
boron nanomaterials, mainly involving boron nanoparticles, boron quantum dots, boron …

Boron cluster-conjugated antisense oligonucleotides (B-ASOs) have already been
developed as therapeutic agents with “two faces”, namely as potential antisense inhibitors of …

New boron carriers with high boron content and targeted cancer-cell delivery are considered
the first choice for boron neutron capture therapy (BNCT) for cancer treatment. Previously …

Humans have always been exposed to tiny particles via dust storms, volcanic ash, and other
natural processes, and our bodily systems are well adapted to protect us from these …

A versatile method for the automated synthesis of composites containing DNA‐
oligonucleotides and boron cluster scaffolds and their assembly into functional …

Boron neutron capture therapy (BNCT) is a binary cancer treatment that involves the
irradiation of 10B-containing tumors with low-energy neutrons (thermal or epithermal). The …